TABLE 2.
Baseline characteristics of hospitalised adults with COVID-19 included in systematic evaluation cohort
| Variable | Subjects with available data | Overall |
| Demographics | ||
| Age years | 411 (100) | 66.0 (53.0–79.0) |
| Sex | 411 (100) | |
| Female | 159 (38.7) | |
| Male | 252 (61.3) | |
| Ethnicity | 390 (94.9) | |
| Asian | 52 (13.3) | |
| Black | 56 (14.4) | |
| White | 234 (60.0) | |
| Mixed | 7 (1.8) | |
| Other | 41 (10.5) | |
| Clinical frailty scale | 411 (100) | 2.0 (1.0–6.0) |
| Comorbidities | ||
| Hypertension | 411 (100) | 172 (41.8) |
| Chronic cardiovascular disease | 410 (99.8) | 108 (26.3) |
| Chronic respiratory disease | 411 (100) | 99 (24.1) |
| Diabetes | 411 (100) | 105 (25.5) |
| Obesity# | 411 (100) | 83 (20.2) |
| Chronic kidney disease | 410 (99.8) | 40 (9.8) |
| Laboratory measurements | ||
| C-reactive protein mg·L−1 | 403 (98.1) | 96.7 (45.2–178.7) |
| Lymphocytes ×109 | 410 (99.8) | 0.9 (0.6–1.4) |
| Lactate dehydrogenase U·L−1 | 183 (44.5) | 395.0 (309.0–511.0) |
| D-dimer ng·mL−1 | 153 (37.2) | 1070.0 (640.0–2120.0) |
| SARS-CoV-2 PCR | 411 (100) | 370 (90.0) |
| Physiological measurements | ||
| Respiratory rate breaths·min−1 | 410 (99.8) | 24.0 (20.0–28.0) |
| Heart rate beats·min−1 | 410 (99.8) | 94.0 (81.2–107.0) |
| Systolic blood pressure mmHg | 411 (100) | 131.0 (115.0–143.0) |
| Oxygen saturation % on air | 403 (98.1) | 91.0 (86.0–95.0) |
| Outcome | ||
| Deteriorated | 411 (100) | 180 (43.8) |
| Died | 411 (100) | 115 (28.0) |
Laboratory and physiological measurements reflect parameters at the time of hospital admission. Data are presented as n (%) or median (interquartile range). COVID-19: coronavirus disease 2019; SARS-CoV-2: severe acute respiratory syndrome coronavirus-2. #: clinician-defined obesity.